Roger Phillips

Prof

Associate Dean (Research and Enterprise), Department of Pharmacy
Department of Pharmacy
Director, Pharmacology and Therapeutics Centre
Associate Membership, Cellular and Molecular Models of Disease Centre

https://orcid.org/0000-0003-3504-177X

Phone01484 471675
EmailR.M.Phillips@hud.ac.uk

Accepting PhD Students

3485 Citations
34 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

3485 Citations
34 h-Index
120 Article
10 Review article
2 Conference contribution
1 Chapter
4 More

10 results

Filter

2018

Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group

Perego, P., Hempel, G., Linder, S., Bradshaw, T. D., Larsen, A. K., Peters, G. J. & Phillips, R. M., 1 Mar 2018, In : Cancer Chemotherapy and Pharmacology. 81, 3, p. 427-441 15 p.

Research output: Contribution to journal › Review article

Open Access

File

8 Citations (Scopus)

2016

Cannabinoid pharmacology in cancer research: A new hope for cancer patients?

Javid, F. A., Phillips, R. M., Afshinjavid, S., Verde, R. & Ligresti, A., 15 Mar 2016, In : European Journal of Pharmacology. 775, p. 1-14 14 p.

Research output: Contribution to journal › Review article

18 Citations (Scopus)

Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs Cytotoxic Reviews Godefridus J. Peters and Eric Raymond

Phillips, R. M., 1 Mar 2016, In : Cancer Chemotherapy and Pharmacology. 77, 3, p. 441-457 17 p.

Research output: Contribution to journal › Review article

86 Citations (Scopus)

2013

EO9 (Apaziquone): From the clinic to the laboratory and back again

Phillips, R. M., Hendriks, H. R. & Peters, G. J., Jan 2013, In : British Journal of Pharmacology. 168, 1, p. 11-18 8 p.

Research output: Contribution to journal › Review article

47 Citations (Scopus)

2007

Tailoring Targeted Therapy to Individual Patients: Lessons to be Learnt from the Development of Mitomycin C

Volpato, M. & Phillips, R. M., May 2007, In : Cancer Genomics and Proteomics. 4, 3, p. 175-186 12 p.

Research output: Contribution to journal › Review article

9 Citations (Scopus)

2004

Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)

Phillips, R. M. & Basu, S., 1 Mar 2004, In : Current Pharmacogenomics. 2, 1, p. 75-82 8 p.

Research output: Contribution to journal › Review article

Open Access

2 Citations (Scopus)

1998

Prospects for bioreductive drug development

Phillips, R. M., Jun 1998, In : Expert Opinion on Investigational Drugs. 7, 6, p. 905-928 24 p.

Research output: Contribution to journal › Review article

11 Citations (Scopus)

1996

Human DT-diaphorase as a candidate for enzyme-directed bioreductive drug development

Phillips, R. M., Dec 1996, In : Drugs of the Future. 21, 12, p. 1247-1256 10 p.

Research output: Contribution to journal › Review article

2 Citations (Scopus)

1994

Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies

Ross, D., Beall, H., Traver, R. D., Siegel, D., Phillips, R. M. & Gibson, N. W., 1994, In : Oncology Research. 6, 10-11, p. 493-500 8 p.

Research output: Contribution to journal › Review article

104 Citations (Scopus)

1990

A Critical Appraisal of the Predictive Value of In Vitro Chemosensitivity Assays

Phillips, R. M., Bibby, M. C. & Double, J. A., 19 Sep 1990, In : Journal of the National Cancer Institute. 82, 18, p. 1457-1468 12 p.

Research output: Contribution to journal › Review article

95 Citations (Scopus)